Thank you, Mr. Chairman.
One of the challenges with this format is that we get to ask you questions and sometimes at the end of the round make comments. I'm sure you'd love to add your two cents in.
In one of the previous rounds, Mr. Smith said he had two questions that he thought were not being answered. One was about antibiotics and why the levels weren't disclosed. Another was about ceftiofur. Maybe you could respond to that. It would be interesting to hear your take on his concerns.